Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Avidity Biosciences to Participate in Upcoming Investor Conferences | ||
By: PR Newswire Association LLC. - 27 Mar 2024 | Back to overview list |
|
SAN DIEGO, March 27, 2024 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced that Avidity management will be participating in the following upcoming conferences:
A live webcast of each of the events, up-to-date event details and archived replays will be available on the "Events and Presentations" page in the "Investors" section of Avidity's website at https://aviditybiosciences.investorroom.com/events-and-presentations. About Avidity Investor Contact: View original content to download multimedia:https://www.prnewswire.com/news-releases/avidity-biosciences-to-participate-in-upcoming-investor-conferences-302100276.html SOURCE Avidity Biosciences, Inc. |
||
|
||
Copyright 2024 PR Newswire Association LLC. | Back to overview list |